Post by Africa CDC

Africa CDC congratulates Biovac, Proparco and partners on the US$180 million investment milestone signed on the sidelines of the Africa Forward Summit to expand vaccine manufacturing capacity in Africa. The investment will support technology transfer, production scale-up, and stronger pathways for African-made vaccines to reach the market — a critical step in advancing Africa’s Health Security and Sovereignty Agenda. Read more: Africa CDC Statement: https://ow.ly/K7Ng50YXGA7 #AfricaCDC #HealthSecurity #AfricaForward